WB
ALT icon

Webster Bank’s Altimmune ALT Stock Holding History

Webster Bank’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-49
Closed – – 505
2019
Q2 		$0 Buy
+49
New +$131 ﹤0.01% 497

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Webster Bank's ALT Position: Q3 2019 in Review

Webster Bank sold out of Altimmune (ALT) in Q3 2019, closing a stake of 49 shares.

Webster Bank first reported a position in ALT in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 30 funds tracked by Wall St. Rank hold ALT as of Q3 2019.

  • Webster Bank reported no remaining Altimmune position as of Q3 2019 after selling out during the quarter.
  • Webster Bank sold 49 Altimmune shares in Q3 2019.
  • Webster Bank first reported a position in Altimmune in Q2 2019 and held it in 1 quarter.
  • Webster Bank's Altimmune position peaked at $0 in Q2 2019.
  • 30 funds tracked by Wall St. Rank held Altimmune as of Q3 2019.

Based on Webster Bank's 13F filing for Q3 2019, filed 2 Oct 2019.